{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:58:47Z","timestamp":1793249927532,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T00:00:00Z","timestamp":1367193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2458-13-406","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T10:14:26Z","timestamp":1367230466000},"source":"Crossref","is-referenced-by-count":40,"title":["Health economics of rubella: a systematic review to assess the value of rubella vaccination"],"prefix":"10.1186","volume":"13","author":[{"given":"Joseph B","family":"Babigumira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,29]]},"reference":[{"issue":"25\u201326","key":"5305_CR1","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1016\/S0264-410X(01)00073-1","volume":"19","author":"SA Plotkin","year":"2001","unstructured":"Plotkin SA: Rubella eradication. Vaccine. 2001, 19 (25\u201326): 3311-3319.","journal-title":"Vaccine"},{"issue":"6","key":"5305_CR2","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/ije\/28.6.1176","volume":"28","author":"FT Cutts","year":"1999","unstructured":"Cutts FT, Vynnycky E: Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 1999, 28 (6): 1176-1184. 10.1093\/ije\/28.6.1176.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"5305_CR3","doi-asserted-by":"publisher","first-page":"S571","DOI":"10.1093\/infdis\/jir472","volume":"204","author":"C Castillo-Solorzano","year":"2011","unstructured":"Castillo-Solorzano C, Marsigli C, Bravo-Alcantara P, Flannery B, Ruiz Matus C, Tambini G, Gross-Galiano S, Andrus JK: Elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis. 2011, 204 (2): S571-S578. 10.1093\/infdis\/jir472.","journal-title":"J Infect Dis"},{"issue":"204","key":"5305_CR4","first-page":"S24","volume":"1","author":"SE Reef","year":"2009","unstructured":"Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S: Progress toward control of rubella and prevention of congenital rubella syndrome\u2013worldwide. J Infect Dis. 2009, 1 (204): S24-S27. 204 Suppl","journal-title":"J Infect Dis"},{"key":"5305_CR5","first-page":"161","volume":"75","author":"World Health Organization","year":"2000","unstructured":"World Health Organization: Rubella vaccines. WHO position paper. Wkly Epidemiol Rec. 2000, 75: 161-172.","journal-title":"Wkly Epidemiol Rec"},{"issue":"48","key":"5305_CR6","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1016\/j.vaccine.2011.08.061","volume":"29","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Rubella vaccines. WHO position paper. Vaccine. 2011, 29 (48): 8767-8768. 10.1016\/j.vaccine.2011.08.061.","journal-title":"Vaccine"},{"key":"5305_CR7","unstructured":"GAVI Alliance: 2013, http:\/\/www.gavialliance.org\/support\/nvs\/rubella ,"},{"issue":"4","key":"5305_CR8","first-page":"264","volume":"80","author":"AR Hinman","year":"2002","unstructured":"Hinman AR, Irons B, Lewis M, Kandola K: Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ. 2002, 80 (4): 264-270.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"5305_CR9","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6 (7): e1000097-10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"5305_CR10","volume-title":"How we classify countries","author":"World Bank Data","year":"2013","unstructured":"World Bank Data: How we classify countries. 2013, http:\/\/data.worldbank.org\/about\/country-classifications ,"},{"issue":"1","key":"5305_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/00005650-200301000-00007","volume":"41","author":"CF Chiou","year":"2003","unstructured":"Chiou CF, Hay JW, Wallace JF, Bloom BS, Neumann PJ, Sullivan SD, Yu HT, Keeler EB, Henning JM, Ofman JJ: Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care. 2003, 41 (1): 32-44. 10.1097\/00005650-200301000-00007.","journal-title":"Med Care"},{"issue":"1","key":"5305_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18553\/jmcp.2003.9.1.53","volume":"9","author":"JJ Ofman","year":"2003","unstructured":"Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, Wade SW, Hay JW: Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003, 9 (1): 53-61.","journal-title":"J Manag Care Pharm"},{"issue":"40\u201341","key":"5305_CR13","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1016\/j.vaccine.2006.05.089","volume":"24","author":"S Al-Awaidy","year":"2006","unstructured":"Al-Awaidy S, Griffiths UK, Nwar HM, Bawikar S, Al-Aisiri MS, Khandekar R, Mohammad AJ, Robertson SE: Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 children. Vaccine. 2006, 24 (40\u201341): 6437-6445.","journal-title":"Vaccine"},{"issue":"12","key":"5305_CR14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/01.inf.0000145479.04559.97","volume":"23","author":"TM Lanzieri","year":"2004","unstructured":"Lanzieri TM, Parise MS, Siqueira MM, Fortaleza BM, Segatto TC, Prevots DR: Incidence, clinical features and estimated costs of congenital rubella syndrome after a large rubella outbreak in Recife, Brazil, 1999\u20132000. Pediatr Infect Dis J. 2004, 23 (12): 1116-1122.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"5305_CR15","first-page":"110","volume":"8","author":"C Saad de Owens","year":"1989","unstructured":"Saad de Owens C, Tristan de Espino R: Rubella in Panama: still a problem. Pediatr Infect Dis J. 1989, 8 (2): 110-115.","journal-title":"Pediatr Infect Dis J"},{"key":"5305_CR16","volume-title":"Final Report, Fourteenth Meeting of the English-speaking Caribbean EPI Managers, Castries, Saint Lucia, 18\u201320 November 1997","author":"Robinson","year":"1998","unstructured":"Robinson: CRS unit costing. Final Report, Fourteenth Meeting of the English-speaking Caribbean EPI Managers, Castries, Saint Lucia, 18\u201320 November 1997. 1998, Pan American Health Organization: Washington (DC)"},{"issue":"1","key":"5305_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2307\/30148380","volume":"15","author":"BH Stover","year":"1994","unstructured":"Stover BH, Adams G, Kuebler CA, Cost KM, Rabalais GP: Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy. Infect Control Hosp Epidemiol. 1994, 15 (1): 18-21. 10.1086\/646812.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"5305_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5694\/j.1326-5377.1994.tb138311.x","volume":"160","author":"MJ Ferson","year":"1994","unstructured":"Ferson MJ, Robertson PW, Whybin LR: Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps. Med J Aust. 1994, 160 (8): 478-482.","journal-title":"Med J Aust"},{"issue":"9","key":"5305_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ajic.2006.04.213","volume":"34","author":"A Celikbas","year":"2006","unstructured":"Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B: Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?. Am J Infect Control. 2006, 34 (9): 583-587. 10.1016\/j.ajic.2006.04.213.","journal-title":"Am J Infect Control"},{"issue":"2","key":"5305_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jiph.2011.11.003","volume":"5","author":"E Alp","year":"2012","unstructured":"Alp E, Cevahir F, Gokahmetoglu S, Demiraslan H, Doganay M: Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?. J Infect Public Health. 2012, 5 (2): 127-132. 10.1016\/j.jiph.2011.11.003.","journal-title":"J Infect Public Health"},{"issue":"1","key":"5305_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.amepre.2003.09.009","volume":"26","author":"J Fontanesi","year":"2004","unstructured":"Fontanesi J, De Guire M, Kopald D, Holcomb K: The price of prevention. cost of recommended activities to improve immunizations. Am J Prev Med. 2004, 26 (1): 41-45. 10.1016\/j.amepre.2003.09.009.","journal-title":"Am J Prev Med"},{"issue":"Suppl 1","key":"5305_CR22","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/clinids\/7.Supplement_1.S200","volume":"7","author":"M Gudnadottir","year":"1985","unstructured":"Gudnadottir M: Cost-effectiveness of different strategies for prevention of congenital rubella infection: a practical example from Iceland. Rev Infect Dis. 1985, 7 (Suppl 1): S200-S209.","journal-title":"Rev Infect Dis"},{"issue":"2","key":"5305_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/01.AOG.0000171110.49973.e3","volume":"106","author":"DM Haas","year":"2005","unstructured":"Haas DM, Flowers CA, Congdon CL: Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating. Obstet Gynecol. 2005, 106 (2): 295-300. 10.1097\/01.AOG.0000171110.49973.e3.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"5305_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1056\/NEJM197602052940604","volume":"294","author":"SC Schoenbaum","year":"1976","unstructured":"Schoenbaum SC, Hyde JNJBL, Crampton K: Benefit-cost analysis of rubella vaccination policy. N Engl J Med. 1976, 294 (6): 306-310. 10.1056\/NEJM197602052940604.","journal-title":"N Engl J Med"},{"issue":"2","key":"5305_CR25","first-page":"69","volume":"5","author":"B Stray-Pedersen","year":"1982","unstructured":"Stray-Pedersen B: Economic evaluation of different vaccination programmes to prevent congenital rubella. NIPH Ann. 1982, 5 (2): 69-83.","journal-title":"NIPH Ann"},{"issue":"7","key":"5305_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2105\/AJPH.75.7.739","volume":"75","author":"CC White","year":"1985","unstructured":"White CC, Koplan JP, Orenstein WA: Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health. 1985, 75 (7): 739-744. 10.2105\/AJPH.75.7.739.","journal-title":"Am J Public Health"},{"key":"5305_CR27","volume-title":"A Cost-Benefit Analysis of Measles-Mumps-Rubella (MMR) Vaccine. Final Report Prepared for the National Immunization Program, Centers for Disease Control and Prevention, USA, 13th May 1994","author":"BR Hatziandreu EJ","year":"1994","unstructured":"Hatziandreu EJ BR, Halpern RE: A Cost-Benefit Analysis of Measles-Mumps-Rubella (MMR) Vaccine. Final Report Prepared for the National Immunization Program, Centers for Disease Control and Prevention, USA, 13th May 1994. 1994"},{"key":"5305_CR28","first-page":"115","volume":"46","author":"P Bjerregaard","year":"1991","unstructured":"Bjerregaard P: Economic analysis of immunization programmes. Scand J Soc Med Suppl. 1991, 46: 115-119.","journal-title":"Scand J Soc Med Suppl"},{"issue":"9\u201310","key":"5305_CR29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0264-410X(97)00281-8","volume":"16","author":"L Pelletier","year":"1998","unstructured":"Pelletier L, Chung P, Duclos P, Manga P, Scott J: A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine. 1998, 16 (9\u201310): 989-996.","journal-title":"Vaccine"},{"issue":"2","key":"5305_CR30","first-page":"74","volume":"26","author":"SA Berger","year":"1990","unstructured":"Berger SA, Ginsberg GM, Slater PE: Cost-benefit analysis of routine mumps and rubella vaccination for Israeli infants. Isr J Med Sci. 1990, 26 (2): 74-80.","journal-title":"Isr J Med Sci"},{"key":"5305_CR31","first-page":"419","volume":"43","author":"O Elo","year":"1979","unstructured":"Elo O: Cost-benefit studies of vaccinations in Finland. Developments in biological standardization. Dev Biol Stand. 1979, 43: 419-428.","journal-title":"Dev Biol Stand"},{"issue":"3","key":"5305_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0033-3506(84)80043-8","volume":"98","author":"M Golden","year":"1984","unstructured":"Golden M, Shapiro GL: Cost-benefit analysis of alternative programs of vaccination against rubella in Israel. Public Health. 1984, 98 (3): 179-190. 10.1016\/S0033-3506(84)80043-8.","journal-title":"Public Health"},{"key":"5305_CR33","volume-title":"Final Report, Fourteenth Meeting of the English-speaking Caribbean EPI Managers, Castries, Saint Lucia, 18\u201320 November 1997","author":"Kommu","year":"1998","unstructured":"Kommu: Follow-up of rubella issues and costing of CRS in Barbados. Final Report, Fourteenth Meeting of the English-speaking Caribbean EPI Managers, Castries, Saint Lucia, 18\u201320 November 1997. 1998, Washington (DC): Pan American Health Organization, http:\/\/hist.library.paho.org\/english\/epi_mana.pdf ,"},{"issue":"10","key":"5305_CR34","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2105\/AJPH.90.10.1545","volume":"90","author":"B Irons","year":"2000","unstructured":"Irons B, Lewis MJ, Dahl-Regis M, Castillo-Solorzano C, Carrasco PA, de Quadros CA: Strategies to eradicate rubella in the English-speaking Caribbean. Am J Publ Health. 2000, 90 (10): 1545-1549.","journal-title":"Am J Publ Health"},{"key":"5305_CR35","first-page":"193","volume":"59","author":"MT Chapalain","year":"1978","unstructured":"Chapalain MT: Perinatality: French cost-benefit studies and decisions on handicap and prevention. CIBA Found Symp. 1978, 59: 193-206.","journal-title":"CIBA Found Symp"},{"key":"5305_CR36","volume-title":"Final Report, Fourteenth Meeting of the English-speaking Caribbean EPI Managers, Castries, Saint Lucia, 18\u201320 November 1997","author":"Kandola","year":"1998","unstructured":"Kandola: CRS cost burden analysis for Guyana. Final Report, Fourteenth Meeting of the English-speaking Caribbean EPI Managers, Castries, Saint Lucia, 18\u201320 November 1997. 1998, Washington (DC): Pan American Health Organization, http:\/\/hist.library.paho.org\/english\/epi_mana.pdf ,"},{"issue":"1","key":"5305_CR37","first-page":"31","volume":"50","author":"H Hudeckova","year":"2001","unstructured":"Hudeckova H, Straka S, Avdicova M, Rusnakova S: Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps. Epidemiol Mikrobiol Imunol. 2001, 50 (1): 31-35.","journal-title":"Epidemiol Mikrobiol Imunol"},{"issue":"Suppl 1","key":"5305_CR38","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1086\/378987","volume":"189","author":"F Zhou","year":"2004","unstructured":"Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM: An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004, 189 (Suppl 1): S131-S145.","journal-title":"J Infect Dis"},{"issue":"8","key":"5305_CR39","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1017\/S0950268809991336","volume":"138","author":"AK Lugner","year":"1172","unstructured":"Lugner AK, Mollema L, Ruijs WL, Hahne SJ: A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome. Epidemiol Infect. 1172, 138 (8): 1172-1184.","journal-title":"Epidemiol Infect"},{"key":"5305_CR40","unstructured":"Historical consumer price indices (1969 to 2012) for baseline countries\/regions: International Financial Statistics, International Monetary Fund. https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDAQFjAA&url=http%3A%2F%2Fwww.ers.usda.gov%2Fdatafiles%2FInternational_Macroeconomic_Data%2FHistorical_Data_Files%2FHistoricalCPIsValues.xls&ei=U6mCUar4Fqe7iwLwjICwBw&usg=AFQjCNFa-CAxLV5VSHwvI3ePYTffQ-lCdQ&sig2=j_OgSEja8QTrfohDH2QPfg&bvm=bv.45960087 ,d.cGE"},{"key":"5305_CR41","first-page":"193","volume":"59","author":"MT Chapalain","year":"1978","unstructured":"Chapalain MT: Perinatality: French cost-benefit studies and decisions on handicap and prevention. Ciba Foundation Symposia. 1978, 59: 193-206.","journal-title":"Ciba Foundation Symposia"},{"key":"5305_CR42","first-page":"301","volume":"86","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Rubella vaccines. WHO position paper. Wkly Epidemiol Rec. 2011, 86: 301-316. 72","journal-title":"Wkly Epidemiol Rec"},{"issue":"48","key":"5305_CR43","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1016\/j.vaccine.2011.08.061","volume":"29","author":"P Who","year":"2011","unstructured":"Who P: Rubella vaccines: WHO position paper\u2013recommendations. Vaccine. 2011, 29 (48): 8767-8768. 10.1016\/j.vaccine.2011.08.061.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"5305_CR44","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1093\/clinids\/7.Supplement_1.S210","volume":"7","author":"SC Schoenbaum","year":"1985","unstructured":"Schoenbaum SC: Benefit-cost aspects of rubella immunization. Rev Infect Dis. 1985, 7 (Suppl 1): S210-S211.","journal-title":"Rev Infect Dis"},{"issue":"7214","key":"5305_CR45","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bmj.319.7214.914","volume":"319","author":"DJ Torgerson","year":"1999","unstructured":"Torgerson DJ, Raftery J: Economic notes. Discounting. BMJ. 1999, 319 (7214): 914-915.","journal-title":"BMJ"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-13-406\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:01:12Z","timestamp":1715256072000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-13-406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["5305"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-13-406","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,29]]},"article-number":"406"}}